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The sites of uptake and retention of inhalants within the respiratory tract influence which tissues are susceptible to damage. Physical and chemical
properties of inhalants, including size, water:air and oil:water partition coefficients, and reactivity or susceptibility to metabolism are the major factors
that affect deposition and retention. The high metabolic capacity of the cells of the olfactory tissue and bronchiolar Clara cells contributes to their
susceptibility to damage from both inhaled and bloodborne toxicants. The major enzymes that metabolize pesticides and many other potential toxi-
cants are the cytochrome P450 and flavin-containing monooxygenases and the carboxylesterases. - Environ Health Perspect 102(Suppl 11):67-70
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Introduction
The sites ofuptake and retention ofinhal-
ants within the respiratory tract influence
which tissues are susceptible to damage
(1,2). Inhaled materials are typically con-
tained in complex mixtures; thus, knowl-
edge of how physicochemical properties
affect the dosimetry of individual compo-
nents is required ifindividual contributions
to toxic effects are to be evaluated. In addi-
tion, careful consideration must be given
to how interspecies variations in biological
parameters affect the dose ofinhalants.
Inhalant concentration times exposure
duration (c x t) is a commonly reported
measure ofdose, but it can lead to decep-
tive interspecies comparative-dose calcula-
tions. Because the ratio ofventilation rate
to mass varies widely among animal species,
the amount ofmaterial inhaled when nor-
malized to body weight also varies widely
for any c x t. For this reason, ventilation
rate, body mass, and numerous other factors
such as rates of metabolism, the nature of
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the metabolites produced, and the suscepti-
bility ofcells and subcellular structures to
toxic effects are all important variables for
comparing doses of inhalants among dif-
ferent species (Figure 1).
The Importance of Dosimetry
in Explaining the Toxicity of
Inhalants
The principal factors affecting the dosimetry
of toxicants to the respiratory tract are the
following: a) the route ofexposure, b) the
physicochemical properties of the inhal-
ants, and c) the metabolic capacity of the
respiratory tract cells.
The respiratory tract is exposed to toxi-
cants by two routes: inhalation and sys-
temic circulation. The dose received by
specific tissues during exposure by inhala-
tion depends on the physicochemical char-
acteristics of the inhalant; the first cells
exposed are epithelial cells. On the other
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hand, during exposure to toxicants circu-
lating in the blood, the first cells exposed
are the endothelial cells of the vasculature,
with the greatest exposure occurring in the
alveolar capillaries because they receive the
entire cardiac output.
The primary factor controlling the site
ofinitial deposition ofinhalants is the size
ofthe inhalant (Figure 2A). For inhalants
classified as particles, there is little re-
entrainment into the airstream once the
airway surface has been contacted. When
inhalant size decreases to molecular dimen-
sions, the inhalants are classified as gases
(or vapors for compounds also occurring in
the liquid state at room temperature), and
the phenomenon ofdesorption after initial
deposition plays a key role in dosimetry.
Molecules absorbed on the nasal or
bronchial mucosa during inhalation and
desorbed during exhalation do not con-
tribute to the overall dose. For gases, the
aqueous solubility (more precisely, high-
Amount
Inhaled
154+- r
X
0
jg 2-
lOppm lOppm
8hr 8hr
Conc.
Time
Min. vol
Metabol.
I-
10 ppm
8 hr
0.2 liter
Uptake
(amount metabolized)
31-
U
z Xo .4 2
10 ppm
8 hr
* 20 liters
'4
c
lOppm lOppm
8hr 8hr
0.2 liter 20 liters
20% 9%
Figure 1. Comparison ofvarious expressions of inhalant dose in rats and people.
Environmental Health Perspectives 67DAHL AND GERDE
t INHALANT DAMETER (nm)
^t" ASEOUS
STATE
SYSTEM
0
'REACTIVITYw
Figure 2. Effects of inhalant size (A) and reactivity (B)
on deposition of inhalants. Reactivity as used here
includes high affinity for the mucosa even when break-
ing or making chemical bonds is not involved.
water and air partition coefficient) of
the inhalants and their reactivity with com-
ponents of the mucosa are the major fac-
tors determining the extent to which
re-entrainment after initial deposition
occurs (Figure 2B).
Anatomy ofthe Respiratory
Tract and Location of
Xenobiotic Metabolism
The topography of the rat nasal cavity is
dominated by complex scroll-like structures
(turbinates) through which air passes
before entering the tubular nasopharynx
(Figure 3). Air inhaled into the lungs
descends through branching tubes of
decreasing diameter until it reaches the gas
exchange region containing the alveoli
(Figure 4). This exchange region is charac-
terized by the thin tissue barrier separating
the endothelial cells ofthe vasculature from
the epithelial cells exposed to air.
Cells with high xenobiotic metabolic
activities in the respiratory tract include the
cells of the nasal transitional and olfactory
epithelia, and the Clara cells ofthe bronchi-
olar epithelium. The nasal respiratory
epithelium, alveolar macrophages, alveolar
type II epithelial cells, and alveolar endothe-
lial cells also have substantial activities.
Partially a result ofthe metabolic activation
oftoxicants, the cells ofthe olfactory tissue
and the bronchiolar Clara cells are frequent
targets for the toxic effects ofinhaled or sys-
temic toxicants (2). Enzyme activities in the
respiratory tract include phase I enzymes
Figure 3. (A) Major structures of the rat nasal cavity ventral view of the hard palate region and four transverse
sections. Abbreviations: L, lumen; mx, maxilloturbinate; ND, nasolacrimal duct; nt, nasoturbinate; RI, root of
incisor tooth; S, septum; V, vomeronasal organ; et, ethomoturbinates; OB, olfactory bulb of the brain. (B) Epithelia
of the nasal cavity. Abbreviations: OE, olfactory epithelium; BG, Bowman's gland; ON, olfactory nerve; SeC, sen-
sory cell; SuC, sustentacular cell; RE, respiratory epithelium; SE, squamous epithelium; TE, transitional epithelium;
nt, nasoturbinate; mx, maxilloturbinate; et, ethmoturbinates; NP, nasopharynx; n, nares. Reprinted with permission
of Dr. Jack Harkema.
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Figure 4. (A) Diagrammatic illustration of the respiratory tract: N, naris; NC, nasal cavity; HP, hard palate; NP,
nasopharynx; T, trachea; EB, extrapulmonary bronchus; IB, intrapulmonary bronchus; TB, terminal bronchiole; RB,
respiratory bronchiole; AD, alveolar duct. (B) Scanning electron photomicrograph of the exposed luminal surfaces
of a terminal bronchiole, TB; respiratory bronchiole, RB; and alveolar duct, AD. Reprinted with permission from Dr.
Jack Harkema.
responsible for initial metabolism of many Modeling Vapor Uptake
lipophilic compounds, phase II enzymes The fundamentals ofthe classic ventilation
responsible for conjugating products of and perfusion-controlled vapor uptake
phase I reactions to highly soluble biomole- model are represented by Equation 1.
cules, and other xenobiotic-metabolizing
enzymes (Table 1).
Environmental Health Perspectives
(I)
RE e
nl
68RESPIRATORY TRACT TOXICANTS
Table 1. Enzymes responsible forxenobiotic metabolism
in the respiratory tract.a
Phase (monooxygenases)
Cytochromes P450
FAD-containing monooxygenase
Phase 11 (transferases)
Glutathione transferases
Glucuronyltransferases
Others
Carboxylesterases
Aldehyde dehydrogenase
Alcohol dehydrogenase
Rhodanese
Epoxide hydrolase
DT-diaphorase
aFrom Dahl (3).
QxPC
Uptake=Q PC w/a x V x[vapor]
w/a
[1]
When the water and air partition coefficient
(PCWIa) ofthe vapor is large relative to the
ventilation rate (V), then uptake is a func-
tion of Vand the vapor concentration
[vapor] (Equation 2).
Uptake = Vx [vapor] [2]
When the PCwia is small relative to V4 then
the uptake rate is a function of the blood
flow rate (Q) and PCwia (Equation 3).
Uptake = QXPC1,a x [vapor] [3]
As PCWia increases, Equation 1 predicts
that uptake will converge to 100% ofthe
inhaled molecules; as PCwia decreases,
uptake should become increasingly inde-
pendent of the ventilation rate, depending
increasingly on the blood flow rate.
Experimental evidence, however, contra-
dicts these predictions of the ventilation
and perfusion model (Figure 5).
The ventilation and perfusion model
fails to correctly predict uptake as a func-
tion of PCwia (or the blood and air parti-
tion coefficient) because of the inability
of this simple model to take into account
the cyclic nature ofbreathing. This inabil-
ity would present no problem ifthe trans-
port of vapor molecules into the blood
deposited on the mucosal surface were fast
relative to the breathing rate. However,
both experimental evidence and theory
indicate that this is not the case (5,6).
Gerde and Dahl (6) developed a mathe-
matical model for nasal uptake of stable
vapors that included a term for diffusion.
Nasal uptake data obtained during cyclic
breathing in the dog and the results ofthe
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Figure 5. Uptake (as % of inhaled vapor) as a function
of the blood and air partition coefficient (from
Johanson (4) and used with permission from copyright
holder).
mathematical model agreed quite well
(Figure 6), showing that diffusion ofvapor
molecules through the mucosa is a key
parameter affecting uptake.
The diffusion and perfusion model
works well for predicting the uptake of
vapors having diffusitivity on the order of
10-9 m2/sec, as is the case for molecules
with oil and water partition coefficients
(PCO,W) _105 diffusing through a homoge-
nous, aqueous barrier. However, the nasal
and lung airway mucosa are not homoge-
nous (Figure 7), so that for compounds
with PC01w>10I, transport through the tis-
sue barrier may be slowed to an important
extent as the molecules are sequestered in
the lipid components ofthe barrier (Figure
8) (7).
The Potential Effect of High
Lipophilicity on the
Disposition of Inhalants
The potential effects of a high PC0,1 on
inhalant molecules are: a) slow transport
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Figure 7. Schematic of airway mucosa.
through the tissue barrier separating the
lumen from the vasculature, b) increased
concentration of a compound in the tissue
barrier (barrier thickness becomes an impor-
tant consideration), and c) longer retention
times and higher attained tissue concentra-
tions that lead to clearance dominated by
metabolism. Thus, it may be expected that
highly lipophilic inhalants (which generally
will be particles because substances having
pCoxt>10 have insubstantial vapor pres-
sures) will be extensively metabolized in
the respiratory tract with possible atten-
dant activation. Moreover, the metabolism
will be most important in the conducting
airways because even very lipophilic com-
pounds are likely to pass relatively quickly
through the thin air and blood barrier of
the alveoli.
Although water-soluble inhalants may
not be extensively metabolized in the respi-
ratory tract, a small fraction metabolized to
toxicants may cause toxic effects. For
example, the water-miscible solvent hexa-
methylphosporamide is a potent nasal car-
cinogen, quite likely as a result of
metabolic release offormaldehyde (8).
Fate of Pesticide in the
Respiratory Tract
Inhaled pesticides as well as other inhalants
may be metabolized by enzymes in the res-
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Figure 6. Uptake of vapors in the dog nasal cavity dur-
ing cyclic breathing (6k. Data points are enclosed in
squares or triangles; curves are from the diffusion and
perfusion mathematical model.
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Figure 8. Schematic of transport of lipophilic inhalant
molecules from airway surface to blood.
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Table 2. Examples of pesticides metabolized by enzymes
that occur in respiratory tract tissue.
Pesticide Enzyme
Allethrin Carboxylesterases
Pyrethrin
Phosphate triesters Carboxylesterases
(act as sinks)
Dichlobenil
Carbaryl
Chlorfenvinphos Cytochromes P450
Naphthalene
Aldrin
Phorates and Flavin-containing
other thioethers monooxygenase
aFrom (9,10).
piratory tract. Carboxylesterases, cyto-
chromes P450, and the flavin-containing
monooxygenases are among the most
important enzymes for pesticide metabo-
lism (Table 2). Pesticides subject to metab-
olism in the respiratory tract are sometimes
activated to toxic metabolites and, because
they contain high levels of metabolizing
enzymes, the olfactory tissue and Clara
cells ofthe bronchioles are frequent targets
(Figure 9).
DICHLOBENIL NAPHTHALENE
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IS, 2R-OXIDE IR, 2S-4ODE
TO)OCWfF: BRONCHIOLAR CLARA CELLS
TOXICITY: NASAL OLFACTORY TISSUE ANIMAL SPECIES: MOUSE
ANIMAL SPECIES: RAT, MOUSE ROUTE OF DEUVERY: PARENTERAL OR INHALATION
ROUTE OF DEUVERY: CIRCULATION
Figure9. Examples of pesticides putatively metabolized to toxic products within the respiratory tract; (A) dichlobenil
(10); (B) naphthalene (11).
Summary and Conclusions
The five main factors to consider when
evaluating the fate of pesticides or any
xenobiotics in the respiratory tract are as
follows: a) Three important determinants
offate and toxicity for xenobiotics in the
respiratory tract are the route ofexposure,
the physicochemical properties ofthe toxi-
cants, and the metabolic capacity of the
respiratory tract cells; b) Reactive or water-
soluble (those having high PCw/a values)
inhaled gases are absorbed largely in the
nasal cavity; c) The deposition sites ofpar-
ticulates are determined by aerodynamic
size; d) Very lipophilic compounds are
slowed in their passage from airways into
blood and may be metabolized to effect
clearance and toxicity; e) Cells ofthe olfac-
tory tissue and the bronchiolar Clara cells
have especially high metabolic capacities
and often activate molecules to toxicants.
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